Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ: HRTS)

에 대한 최신 뉴스 Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ:HRTS)

Healthcare

Other

TEMA ETFs

The investment seeks to provide long-term growth of capital by investing in companies leading the fight against diabetes, obesity and cardiovascular diseases. Obesity is on the cusp of a revolution in therapeutics, while heart disease, the most common cause of death, is witnessing a renaissance of therapies driven by genetic insights and tools.

Tema Cardiovascular and Metabolic ETF

Biotech

Equities

Large Cap

Sector ETFs

Health Care

Small Cap

Global

Exclusives

Tech

ETFs

ABBV

ALNY

AMGN

HRTS

테마(Tema) ETFs의 설립자이자 CEO인 마우리츠 팟(Maurits Pot)은 비만 치료를 위한 GLP-1 약물 시장은 1조 달러 이상으로 급등할 것으로 예상된다고 벤징가(Benzinga)와의 독점 인터뷰에서 그의 낙관적인 예측을 공유했다. 

단독: GLP-1 체중 감량 약물은 수조 달러 규모의 시장 가능성, 테마 ETFs CEO의 전망

Tema GLP-1, Obesity & Cardiometabolic ETF

Canadian Natural Res (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNQ#NYSE">CNQ</a>) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.93 by 1.08 percent. This is a 9.3 percent increase over earnings of $0.86 per share from the same period last year.

Earnings

Earnings Beats

News

Canadian Natural Res Q4 2024 Adj EPS $0.94 Beats $0.93 Estimate

ProFrac Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACDC#NASDAQ">ACDC</a>) reported quarterly sales of $454.70 million which missed the analyst consensus estimate of $479.26 million by 5.13 percent. This is a 7.03 percent decrease over sales of $489.10 million the same period last year.

Earnings Misses

ACDC

ProFrac Holding Q4 Sales $454.70M Miss $479.26M Estimate, Net loss $100M Compared To Net Loss Of $44M YoY

ECARX Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECX#NASDAQ">ECX</a>) ("ECARX" or the "Company"), a global mobility technology provider, today announced an award by the Volkswagen Group to provide advanced digital cockpit solutions for vehicles sold globally under the Volkswagen and Skoda brands.
ECARX will provide a complete digital cockpit solution, including the integrated hardware and software of the ECARX Antora&#xAE; 1000 computing platform and ECARX Cloudpeak&#xAE; software architecture.
A significant number of cars will be launched with a user experience defined by Volkswagen Group and ECARX. Initial launches are planned in Brazil and India, with further markets for growth potential.
Antora&#xAE; 1000 is ECARX's fourth-generation digital cockpit computing platform, based on a 7nm high-performance SE1000 System-on-Chip (SoC) from SiEngine.
ECARX Cloudpeak&#xAE;, a flexible and modular platform based on the Android Automotive operating system and Linux, is able to integrate services including Google Maps, Google Assistant voice control and the Google Play store, along with mobile integrations including Android Auto and Apple CarPlay, along with other regional mobile ecosystems and services.
The computing platform's operating system and the ECARX Cloudpeak&#xAE; software stack are developed entirely in-house by ECARX, to deliver a compact, affordable and energy-efficient system able to support a high-quality user experience based on Android OS and supporting Google Automotive Services, with further services and details to be announced.
The combination of ECARX computing platform and architecture will power the intelligent cockpit of Skoda and Volkswagen-branded vehicles.

VWAGY

ECARX Wins Volkswagen Deal to Power Digital Cockpits in Skoda and VW Cars Globally

General

DNLI

On Wednesday, Denali Therapeutics Discontinued The Active Treatment Extension In Regimen G Of The Phase 2/3 HEALEY ALS Platform Trial Of eIF2B agonist DNL343 For Amyotrophic Lateral Sclerosis-8K

HUTCHMED (China) Limited ("<a href="https://www.globenewswire.com/Tracker?data=ycS5bfwHqeeTsrpust60oGqZK1WeHdYyQMcHuxCjDWy4M2_9qv_0qtluJNzPp9vLQfVNiUYCVFW-pIZF-Ib2wg==">HUTCHMED</a>") (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has completed enrollment of its a Phase II trial of fanregratinib (HMPL-453) for intrahepatic cholangiocarcinoma ("IHCC") patients with fibroblast growth factor receptor ("FGFR")2 fusion/rearrangement.&nbsp;
The study is a single-arm, multi-center, open-label, Phase II registration study to evaluate the efficacy, safety and pharmacokinetic of fanregratinib in treating advanced IHCC patients with FGFR2 fusion/rearrangement. Primary endpoint is objective response rate (ORR). Secondary endpoints include progression-free survival (PFS), disease control rate (DCR), duration of response (DoR) and overall survival (OS). A total of 87 patients were enrolled into the registration phase of the study. Additional details may be found at clinicaltrials.gov using identifier&nbsp;<a href="https://www.globenewswire.com/Tracker?data=7t73H6gqnzdTPV6m-XAeO7Yd1vbZD8DULUeMNDfhUoCt5RrzZM4VcmhTqx9Zbf1Pab7aslXGeY2AdU7yHN9cjYF7BkLu0sTm7lsG_3yoMvJhwwpCqv9xH7i3reggDfGY">NCT04353375</a>.
The first patient received the first dose in March 2023 and HUTCHMED expects to announce topline results from the study around the end of 2025. If favorable, the results could enable a New Drug Application submission to China's National Medical Products Administration (NMPA).

HUTCHMED Completes Enrollment for Phase II Trial of Fanregratinib in Liver Cancer Patients

EV giant Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is reportedly looking to put up a third megafactory in Texas after starting production at its Shanghai facility in February.
What Happened: Tesla will operate the facility out of two buildings at the Empire West Industrial Park near Houston, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-03-06/tesla-gets-tax-sweetener-for-houston-area-megapack-factory?srnd=all&amp;sref=vEQJzSks">reported</a>, citing a tax abatement agreement. 
A megafactory is a Tesla facility dedicated to the production of Megapacks. 
Megapack is a powerful battery manufactured by the company for large-scale energy storage.&nbsp;Each unit can store over 3.9 Megawatt-hours of energy, which is enough to power an average of 3,600 homes for an hour.
Production at the&nbsp;<a href="https://www.benzinga.com/24/12/42680075/tesla-exec-says-we-will-be-ready-to-efficiently-produce-autonomous-vehicles-as-shanghai-megafactory-nears-completion" target="_blank" rel="noreferrer noopener">Shanghai megafactory</a>, the company's first factory dedicated to the production of energy storage products outside the U.S., started in February.&nbsp;Currently, Tesla has only one other factory dedicated to manufacturing megapacks, located in Lathrop, California. The Lathrop facility has the capability of producing 40 GWh of energy storage products every year.
The company&#8217;s gigafactory in Nevada can also manufacture energy storage products, in addition to vehicle powertrains and batteries. 
Why It Matters: Tesla reported revenue of over $3 billion from its energy generation and storage segment in the fourth quarter of 2024, or more than double the $1.44 billion reported in the corresponding quarter of 2023, upon deploying a record <a href="https://www.benzinga.com/25/01/42780335/teslas-evergy-storage-deployements-rise-in-q4-even-as-vehicle-deliveries-disappoint" target="_blank" rel="noreferrer noopener">11.0 GWh of energy storage products</a>.
Revenue from the energy segment accounted for about 12% of the company's total revenue in the quarter, while the automotive segment accounted for 77%. The company reported quarterly&nbsp;<a href="https://www.benzinga.com/news/earnings/25/01/43321103/tesla-q4-earnings-highlights-revenue-miss-eps-miss-ev-updates-automaker-says-2025-will-be-a-seminal-year" target="_blank" rel="noreferrer noopener">total revenue</a>&nbsp;of $25.71 billion, missing a street consensus estimate of $27.26 billion, owing to an 8% drop in automotive revenue.
Tesla continues to be&nbsp;<a href="https://www.benzinga.com/news/24/10/41537560/teslas-energy-segment-boom-in-q3-sparks-leadership-changes-veteran-mike-snyder-promoted-as-vp" target="_blank" rel="noreferrer noopener">hopeful for its energy segment</a>&nbsp;for it said in January that it expects energy storage deployment to grow at least 50% year-over-year in 2025. Both the powerwall and megapack continue to be supply-constrained as it opens to new markets, the company added.
Tesla CEO Elon Musk said during the company&#8217;s fourth-quarter earnings call that the company is putting up a third megapack facility. The CEO, however, did not reveal the location of the factory then. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44101333/fords-mustang-mach-e-leads-companys-us-ev-sales-in-feb-but-trump-tariffs-threaten-future" target="_blank" rel="noreferrer noopener">Ford's Mustang Mach-E Leads Company's US EV Sales In Feb But Trump Tariffs Threaten Future</a></li>
</ul>
Photo courtesy: Shutterstock

TSLA

Elon Musk's Tesla To Build 3rd Megafactory In Texas After Kicking Off Production In Shanghai: Report

Dingdong (Cayman) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDL#NYSE">DDL</a>) reported quarterly earnings of $0.08 per share. This is a 700 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $808.99 million. This is a 15.02 percent increase over sales of $703.31 million the same period last year.

Dingdong (Cayman) Reported Q4 Adj EPADS $0.08 and Sales $808.99M

Chris Wright, the U.S. Secretary of Energy, has granted an extension for the export permit of the Golden Pass LNG project. This project is a collaborative effort between&nbsp;QatarEnergy&nbsp;and&nbsp;ExxonMobil&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) and is currently under construction in Sabine Pass, Texas.
What Happened: The Department of Energy announced that the extension will provide additional time for the launch of LNG exports to major markets in Asia and Europe from the $10 billion project. The new deadline for the start of exports has been pushed back from Sept. 30, 2025, to March 31, 2027.
The Golden Pass project, expected to begin LNG production in late 2025, will become the ninth-largest export terminal&nbsp;in the U.S. once it&#8217;s operational. QatarEnergy has a 70% stake in the joint venture, with ExxonMobil holding the remaining 30%.
Tala Goudarzi, an official from the department&#8217;s&nbsp;fossil energy and carbon management&nbsp;division, shared that the Golden&nbsp;Pass was the first project authorized by the DOE for exports to countries without a free trade agreement during the initial Trump administration.
The project developers requested an extension in August due to a shift in main contractors&nbsp;and the need for contingency time due to uncertainties in a project of this scale. The DOE stated that upon completion,&nbsp;Golden Pass will be capable of exporting up to&nbsp;2.57 billion cubic feet of LNG per day. 
SEE ALSO: <a href="https://www.benzinga.com/news/25/03/44153281/no-chick-fil-a-on-sundays-heres-where-fast-food-fans-flock-instead">No Chick-fil-A On Sundays? Here&#8217;s Where Fast-Food Fans Flock Instead</a>
Why It Matters: The U.S. is the largest exporter of LNG in the world. On that note, Secretary Wright stated, "Exporting U.S. LNG supports American jobs, bolsters our national security and strengthens America's position as a world energy leader.&#8221;
The Trump administration is resuming approvals for LNG exports after former President Joe Biden temporarily halted them to assess the economic and environmental impacts of the rapidly growing industry.
This extension comes at a time when ExxonMobil&#8217;s shares have been under pressure. On Wednesday, ExxonMobil&#8217;s shares fell to <a href="https://www.benzinga.com/news/25/03/44150023/why-exxon-mobil-xom-stock-hit-a-new-52-week-low-today">a new 52-week low</a>, largely due to a drop in oil prices following a rise in U.S. inventories and OPEC+&#8217;s decision to proceed with its planned April wind-down of production cuts. 
The extended permit for the Golden Pass project could potentially provide a much-needed boost to ExxonMobil&#8217;s operations. 
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44143660/howard-lutnick-says-president-definitely-thinks-theres-a-bitcoin-strategic-reserve">Howard Lutnick Says &#8216;President Definitely Thinks There&#8217;s A Bitcoin Strategic Reserve&#8217;</a></li>
</ul>

Markets

ExxonMobil And QatarEnergy's Golden Pass LNG Project Gets Extended Export Permit From US Energy Department

Deutsche Lufthansa (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DLAKY#OTC">DLAKY</a>) reported quarterly earnings of $0.49 per share. This is a 716.67 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $10.08 billion. This is a 6.88 percent increase over sales of $9.43 billion the same period last year.

DLAKY

Deutsche Lufthansa Q4 EPS $0.49 and Sales $10.08B

French satellite operator Eutelsat Communications S.A. has risen over 630% since Monday, following President Donald Trump&#8216;s announcement of a freeze in Ukraine&#8217;s military aid.
What Happened: Eutelsat&#8217;s surge comes as the French company is in talks with the European Union to replace SpaceX&#8217;s Starlink satellite service in Ukraine, according to <a href="https://in.investing.com/news/stock-market-news/eutelsat-in-talks-with-eu-to-replace-starlink-in-ukraine-93CH-4705787">a</a> report by Investing.com.
CEO Eva Berneke told Bloomberg TV on Thursday that the company was looking into the requests of replacing several Starlink terminals in Ukraine. While the company already has a presence in Ukraine, Berneke said that it would take a few months to replace around 40,000 Starlink terminals.
Elon Musk owned SpaceX makes Starlink, which is a satellite internet service that delivers high-speed, low-latency broadband globally, especially to remote areas underserved by traditional internet providers.
President Trump on Monday temporarily suspended U.S. military aid to Ukraine to pressure Ukrainian President Volodymyr Zelenskyy into peace negotiations with Russia. According to the White House, the freeze will remain in place until Trump determines that Ukraine has made a meaningful effort toward diplomatic talks with Moscow.
See Also: <a href="https://www.benzinga.com/25/03/44138112/defense-stocks-take-centerstage-as-donald-trump-freezes-ukraine-military-aid-heres-a-list-of-top-global-defense-etfs-to-watch">Defense Stocks In Focus As Trump Freezes Ukraine Military Aid: Here&#8217;s A List Of Top Global Defense ETFs To Watch</a>
Why It Matters: Eutelsat&#8217;s shares have surged 631.1% from €1.19 or $1.29 on Friday, Feb. 28, to €8.7 or $9.40 intraday on Thursday.
Investor <a href="https://www.benzinga.com/25/03/44138112/defense-stocks-take-centerstage-as-donald-trump-freezes-ukraine-military-aid-heres-a-list-of-top-global-defense-etfs-to-watch">interest in defense stocks</a> has increased after Trump&#8217;s announcements in anticipation of increased demand for their products and services as European nations are rallying to support Ukraine.
British Prime Minister Keir Starmer has pledged a £2.26 billion loan for military supplies. Meanwhile, Germany&#8217;s prospective coalition government is planning to create a €500 billion or $540.532 billion infrastructure fund to modernize the military and boost economic growth, reported Reuters.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell in premarket on Thursday. SPY decline 0.68% to $579.10&nbsp;and QQQ was down 0.84% to $497.79, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
On Wednesday, the SPY advanced 1.07% to $583.06, and the QQQ rose 1.30% to $502.01.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44135177/trump-seeks-to-end-chips-act-who-stands-to-lose-heres-a-list-of-beneficiaries-that-could-be-affected" target="_blank" rel="noreferrer noopener">Trump Seeks To End CHIPS Act: Who Stands To Lose? Here's A List Of Beneficiaries That Could Be Affected</a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Starlink's European Rival, Up Over 600% Since Trump Halted Ukraine Aid, Now Plans To Replace Elon Musk's Satellite Internet Service In War-Torn Nation

Dividend Payment
The Company announced that its board of directors (the "Board") approved an annual cash dividend for the year ended December 31, 2024 of US$0.5 per ordinary share, or US$1.0 per ADS, to holders of ordinary shares and holders of ADSs, respectively, as of the close of business on April 8, 2025 Beijing/Hong Kong Time and New York Time, respectively, payable in U.S. dollars. The aggregate amount of the dividend is expected to be approximately US$1.5 billion, as calculated on the current number of the Company's total issued and outstanding shares, which may be subject to minor adjustment by the record date. The payment date is expected to be on or around April 23, 2025 and on or around April 29, 2025 for holders of ordinary shares and holders of ADSs, respectively.

Dividends

JD.com Approved Annual Cash Dividend Of $1.00 Per ADS

JD.com Q4 Adj EPADS $1.02 Beats $0.90 Estimate, Sales $47.54B Beat $45.96B Estimate

Anatoly Yakovenko, the co-founder of the Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) ecosystem, argued against a federal government-controlled cryptocurrency reserve Wednesday, citing a threat to decentralization.
What Happened: In an X post, Yakovenko outlined his order of preference for a potential cryptocurrency reserve.
&#8220;No reserve, because if you&nbsp;want decentralization to fail, you'd&nbsp;put the government in charge&nbsp;of it,&#8221; he stated as his first and the most ideal choice.
However, if reserves must be set up, Yakovenko said they should be managed by states as a &#8220;hedge&#8221; against the Federal Reserve making a mistake.
In the case of a federally administered reserve, Yakovenko proposed basing it on &#8220;objectively measurable requirements.&#8221; 
&#8220;I don't care what they are, they can even be constructed such that only Bitcoin satisfies them right now, they just must be objectively measurable and rationally justified,&#8221; he explained his point.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">My reserve order of preference 1. No reserve, because if you want decentralization to fail you'd put the government in charge of it. 2. Or states run their own reserve as a hedge against the fed making a mistake 3. Or if there has to be a reserve, it's based on objectively… <a href="https://t.co/LfYXCIeRnG">https://t.co/LfYXCIeRnG</a>
&mdash; toly &#x1f1fa;&#x1f1f8; (@aeyakovenko) <a href="https://twitter.com/aeyakovenko/status/1897517764119830775?ref_src=twsrc%5Etfw">March 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
When questioned if this was an indirect confirmation that no one from Solana pitched SOL for inclusion in the recently announced U.S. cryptocurrency reserve, Yakovenko stated, &#8220;No one asked me, and I didn&#8217;t pitch it.&#8221;
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/03/44159088/microsoft-might-have-given-bitcoin-investments-a-miss-for-now-but-one-of-its-largest-investors-has-been-an-avid-advocate-of-cryptos-blockchains">Microsoft May Have Given Bitcoin Investments A Miss But A Large MSFT Stock Holder Is A Strong Crypto, Blockchain Advocate</a>
Why It Matters: Yakovenko&#8217;s comments come in the wake of the surprise announcement of a strategic reserve comprising of top coins such as Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>), and SOL. 
The idea of including coins other than Bitcoin has sparked criticism from certain quarters, including some of President Donald Trump&#8217;s <a href="https://www.benzinga.com/25/03/44107003/trump-faces-backlash-over-crypto-reserve-plan-from-bitcoin-supporters-including-his-own-dont-think-the-government-should-be-pumping-our-crypto-bags-with-taxpayer-money">supporters</a>. Coinbase CEO Brian Armstrong also <a href="https://in.benzinga.com/25/03/44070857/coinbase-ceo-brian-armstrong-thinks-having-a-bitcoin-only-crypto-reserve-best-option-while-arthur-hayes">stated </a>that having just Bitcoin in the reserve would be the &#8220;best option.&#8221;
That said, Commerce Secretary Howard Lutnick <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44143660/howard-lutnick-says-president-definitely-thinks-theres-a-bitcoin-strategic-reserve">hinted </a>that Bitcoin might be granted a special status in the proposed reserve, while other tokens would be treated differently but positively.
All eyes will be on Friday&#8217;s <a href="https://www.benzinga.com/25/03/44064928/trump-to-host-first-ever-white-house-crypto-summit-next-friday-btc-surges-past-85000-doge-surges-over-10" target="_blank" rel="noreferrer noopener">White House crypto summit</a> to get a more comprehensive understanding of the reserve.
Price Action: At the time of writing, SOL was exchanging hands at $6.23, up 13.61% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/03/44157760/peter-schiff-predicts-a-bitcoin-strategic-reserve-will-accelerate-dollars-demise-the-ultimate-winner-will-be-gold">Peter Schiff Predicts A Bitcoin Strategic Reserve Will &#8216;Accelerate&#8217; Dollar&#8217;s Demise: &#8216;Ultimate Winner Will Be Gold&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$BTC

$ETH

$SOL

$XRP

Solana Co-Founder Says A Federally Controlled Crypto Reserve Will Harm Decentralization Ethos, Proposes States Control Their Own Reserves

Offerings

HCXY

Reported Earlier, Hercules Capital Announced That It Has Agreed To Sell To The Initial Purchasers In A Private Offering, $250.0M Aggregate Principal Amount Of Its 4.75% Convertible Unsecured Notes Due 2028

Reported Earlier, Forestar Group Announced That It Has Priced An Offering Of $500M Aggregate Principal Amount Of 6.500% Senior Unsecured Notes Due 2033

Reported Earlier, Bread Financial Announced The Pricing Of Its Previously Announced Offering Of $400M In Aggregate Principal Amount Of Its 8.375% Fixed-rate Reset Subordinated Notes Due 2035

2025 guidance
<ul>
<li>South Bow has reduced its outlook for normalized EBITDA for its Marketing segment by approximately $30 million relative to 2024, due to continued impacts of WCSB crude oil pipeline capacity exceeding supply and South Bow's response to market uncertainty caused by the potential for, and continuation of, tariffs, including the unwinding of certain positions to minimize South Bow's exposure to further pricing volatility.</li>
<li>South Bow anticipates that its interest expense for 2025 will be approximately $325 million, within a range of 2%, and that the Company's current tax rate will range from 23% to 24%.</li>
<li>Distributable cash flow is expected to be approximately $535 million, within a range of 3%, which South Bow will use to fund its expected annual dividend of $416 million ($2.00/share), subject to approval and declaration by the Board, and investments required to continue advancing the Blackrod Connection Project.</li>
<li>South Bow expects that its net debt-to-normalized EBITDA ratio will increase modestly through the course of 2025 as the Company continues to invest in the Blackrod Connection Project and incur one-time costs of approximately $40 million to $50 million associated with the Spinoff. Consistent with the Company's outlook on leverage, South Bow anticipates exiting 2025 with a net debt-to-normalized EBITDA ratio of approximately 4.8 times and that the Company will begin reducing its leverage once the Blackrod Connection Project starts generating cash flow in 2026.</li>
<li>South Bow plans to invest approximately $110 million, within a range of 3%, in growth capital expenditures for the Blackrod Connection Project in 2025. The total expected capital cost of the project is estimated to be $180 million, targeted to be ready for in-service in early 2026. As of Dec. 31, 2024, South Bow has invested $62 million in the project.</li>
<li>Maintenance capital expenditures are estimated to be approximately $65 million, within a range of 3%, in 2025, as South Bow proactively completes maintenance activities while demand for uncommitted capacity is expected to be subdued, and invests in information services infrastructure. These expenditures are generally recoverable through South Bow's tolling arrangements.</li>
</ul>
South Bow's 2025 annual guidance and a review of 2024 actual results are outlined below:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>$ millions, except percentages 1</td>
<td>2024 Actuals</td>
<td>2025 Guidance</td>
</tr>
<tr>
<td>Normalized EBITDA</td>
<td>1,091</td>
<td>1,010 ± 3%</td>
</tr>
<tr>
<td>Interest expense</td>
<td>388</td>
<td>325 ± 2%</td>
</tr>
<tr>
<td>Current tax rate (%)</td>
<td>23%</td>
<td>23% - 24%</td>
</tr>
<tr>
<td>Distributable cash flow</td>
<td>608</td>
<td>535 ± 3%</td>
</tr>
<tr>
<td>Capital expenditures</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Growth</td>
<td>73</td>
<td>110 ± 3%</td>
</tr>
<tr>
<td>Maintenance 2</td>
<td>61</td>
<td>65 ± 3%</td>
</tr>
</tbody>
</table>
</figure>

Guidance

SOBO

South Bow Projects 2025 Normalized EBITDA Of Approximately $1.01B, Reaffirms Its Long-term Normalized EBITDA Growth Outlook Of 2% To 3%

South Bow Reports Q4 2024 GAAP EPS Of $0.54 Vs. $0.45 YoY, Sales Of $488M Vs. $540M YoY

Skanska is investing about SEK 1 billion in the first phase of the office complex Solna Link at Solna Station in Arenastaden, Sweden. The construction contract is worth about SEK 480M, which will be included in the order bookings for Sweden for the first quarter 2025.
The first phase of the nine-storey office building will have a leasable area of approximately 16,000 square meters. The entire Solna Link, located along the tracks at Solna Station, will encompass about 36,000 square meters. In addition to office space, the ground floor will house a gym, conference rooms, lounge, restaurant, café, and bicycle service. Just a few minutes from Solna Link is Westfield Mall of Scandinavia with shops, restaurants, and all other types of services.
The project will be LEED certified with the ambition to achieve Platinum level, and it is also pre-certified according to NollCo2 and WELL Gold.
Construction work is set to begin in March 2025 and the office building is planned for completion in the first quarter of 2027.

SKBSY

Skanska Invests SEK 1B in Solna Link Office Complex, Begins Construction in March 2025

FuelCell Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCEL#NASDAQ">FCEL</a>) and Malaysia Marine and Heavy Engineering Sdn Bhd (MMHE), a wholly owned subsidiary of Malaysia Marine and Heavy Engineering Holdings Berhad (KLSE: MHB), have announced the signing of a Joint Development Agreement (JDA) to co-develop large-scale hydrogen production systems and technologies across Asia, New Zealand, and Australia.
Building on a memorandum of understanding signed in February 2023, the JDA represents a pivotal step for the two companies, driven by a shared vision to make clean hydrogen production easily accessible and viable. The collaboration underscores FuelCell Energy and MHB's commitment to advancing green energy solutions and supporting global decarbonization and energy transition goals.
Under the terms of the JDA, the two companies will bring together FuelCell Energy's cutting-edge solid oxide electrolyzer (SOEC) technology and MHB's expertise in large-scale fabrication to develop modular solutions that support rapid deployment of commercial hydrogen production.
&nbsp;
Project Award: Detailed Feasibility Study (DFS) in Malaysia
In conjunction with the JDA, FuelCell Energy and MHB are collaborating to support a contract awarded to FuelCell Energy for a Detailed Feasibility Study (DFS) of a low-carbon fuel production facility in Malaysia. The DFS will evaluate the production of low-carbon fuel utilizing SOEC technology with carbon dioxide and water as feedstocks.
Additionally, as part of the DFS, the companies will collaborate with KBR LLC, which will provide its proprietary low-carbon fuel synthesis technology.
The project aligns with Malaysia's goals to achieve net-zero carbon emissions by 2050, while advancing its national hydrogen value chain.

Government

Regulations

FCEL

FuelCell Energy and MMHE Partner to Expand Large-Scale Hydrogen Production Across Asia and Australia

Tema ETF Trust Tema Obesity & Cardiometabolic ETF

테마(Tema) ETFs의 설립자이자 CEO인 마우리츠 팟(Maurits Pot)은 비만 치료를 위한 GLP-1 약물 시장은 1조 달러 이상으로 급등할 것으로 예상된다고 <a href="https://www.benzinga.com/exclusives">벤징가(Benzinga)와의 독점 인터뷰</a>에서 그의 낙관적인 예측을 공유했다. 
마우리츠는 &#8220;장기적으로 이것은 일라이 릴리(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)와 노보 노디스크(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) 사이의 양대 경쟁이 아니라고 생각한다&#8221;고 말하며, 체중 감량 시장에서 널리 퍼져 있는 두개의 기업이 전체 시장을 과점(duopoly)하는 개념에 도전했다.
Pot은 체중 감량 치료제에 대한 수요 증가와 GLP-1 약물의 적용 확대가 이 1조 달러 규모의 시장 기회를 주도할 것이라고 예측한다.
2023년 11월, 테마 ETFs는 체중 감량에 초점을 맞춘 최초의 ETF인 Tema GLP-1, Obesity and Cardiometabolic ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRTS#NYSE">HRTS</a>)를 출시했다. SPDR S&amp;P 500 ETF Trust(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)에서 추적한 바와 같이, 이 펀드는 개시 이후 25% 상승하여 S&amp;P 500의 성과를 약간 앞섰다.
이 ETF의 주요 보유 종목으로는 일라이 릴리, 암젠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), 노보 노디스크, 앨라일람 파마슈티컬스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>)가 있으며 각각 약 5~6%의 비중을 갖고 있다. 이 HRTS 포트폴리오는 또한 40개 이상의 기타 체중 감량 관련 회사들로 구성되어 있다.
차트: Tema GLP-1, Obesity and Cardiometabolic ETF는 설정 이후 S&amp;P 500을 능가
<figure class="wp-block-image size-large"><a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent070524&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-422177" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/05152109/image-10-1024x652.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/05152109/image-10-1024x652.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/05152109/image-10-300x191.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/05152109/image-10-768x489.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/05152109/image-10-1536x978.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/05152109/image-10.png 1662w" alt="" width="1024" height="652" /></a></figure>
차트: <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent070524&amp;t=be2bearmibe3na1">벤징가 프로</a> 
<h3 class="wp-block-heading">체중 감량 치료: 응용 분야 및 혁신 확대</h3>
팟(Pot)에 따르면, GLP-1 약물은 곧 체중 감량을 넘어 당뇨병, 심장, 간 및 신장 질환에 적용되고 암, 알츠하이머병, 파킨슨병 및 기타 신경성 질환과 같은 질환을 치료할 수 있는 가능성이 있다고 한다.
기존 주사 방법은 경구 투여 또는 투여 빈도 감소에 초점을 맞춘 새로운 접근법으로 인해 어려움을 겪고 있다. 혁신의 목표는 주 1회 주사에서 잠재적으로 2개월에 한 번으로 전환하는 등 치료법을 덜 침습적으로 만들거나 경구 정제 생산과 같이 제조하기를 훨씬 쉽게 만드는 것이다.
비만은 당뇨병, 심장병, 암 등 다양한 질병을 유발한다. 따라서 비만을 해결하면 여러 가지 건강 문제를 완화하고 GLP-1 약물의 시장 잠재력을 증폭시킬 수 있다.
이 시장은 일라이 릴리 및 노보 노디스크를 넘어 다양한 질병 영역을 다루게 될 것으로 예상된다.
팟은 비만, 당뇨병, 잠재적으로 알츠하이머병이나 암에 대한 용도를 언급하면서 &#8220;세계 인구의 절반이 GLP-1이나 다른 체중 감량 약물을 1차 예방 등의 다른 이유로 복용하는 세상을 볼 수 있다&#8221;라고 말했다.
<h3 class="wp-block-heading">1조 달러 예상의 배경</h3>
전 세계 비만 인구는 2035년까지 10억 명에서 20억 명으로 두 배로 늘어날 것으로 예상된다. 이러한 성장이 없더라도 기존 10억 명의 비만 인구는 상당한 시장을 대표한다.
장기 치료가 현재 비만 인구의 20%에게만 도달한다면, 이는 현재 당뇨병 약물의 보급률과 유사하게 2억 명에 해당한다. 연간 1인당 약가가 12,000달러에서 6,000달러로 인하된다고 가정하면 GLP-1 의약품 시장은 1조 달러를 넘어설 수 있다고 팟이 설명했다.
골드만삭스는 시장 규모를 1,000억~1,300억 달러로 추정하지만 팟은 암, 알츠하이머병, 파킨슨병에 대한 투기적 적용을 고려하기 전에도 시장이 1조 달러에 도달할 수 있다고 믿고 있다. 시장 규모는 지속적으로 과소평가되어 왔으며 추정치는 몇 달마다 증가하고 있다.
특허 만료는 또한 시장을 형성할 것이다. 미국에서는 오젬픽(Ozempic)/위고비(Wegovy)의 특허가 2032년에 만료되고, 유럽에서는 2031년, 중국에서는 2026년에 만료된다.
"특허가 만료되기 전에는 1조 달러 규모의 시장이 될 것이라고 생각한다"라고 팟은 말했다.
<h3 class="wp-block-heading">중소형주에 초점 맞추기</h3>
왜 투자자들이 소수의 대형주 대신 다양한 체중 감량 관련 주식에 집중해야 하는지 묻는 질문에 팟은 일라이 릴리와 같은 대기업들과 달리 &#8220;이 거대한 중소형 생명공학 시장에서 긍정적인 임상 결과의 영향이 훨씬 더 높다&#8221;고 설명했다. 
그는 포트폴리오 균형으로 대형주를 보유하는 것의 중요성을 강조했지만 소규모 회사들이 장기적으로 더 높은 수익을 제공할 수 있다고 지적했다.
팟은 생명공학 부문이 인수합병으로 성숙해 있음을 강조했다. 지난해에만 가치가 10억 달러를 초과하는 생명공학 M&amp;A 거래가 22건 있었다.
머크 앤드 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>), 화이자(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), 또는 애브비(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>)와 같이 비만 사업이 없는 주요 헬스케어 회사들이 인수를 모색할 가능성이 높다.
지금 읽기
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/06/39143220/exclusive-tema-american-reshoring-etf-outshines-s-p-500-without-owning-magnificent-7-stocks-they-can">단독: Tema American Reshoring ETF는 7개 주식을 보유하지 않고도 S&amp;P 500을 능가</a></li>
</ul>
사진: 셔터스톡


Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Tema GLP-1, Obesity & Cardiometabolic ETF

뉴스

에 대한 최신 뉴스 Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ:HRTS)

일요일, 7월 07, 2024

뉴스

파트너 / 기고자

벤징가 글로벌